IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV11I8A188

Fractional flow reserve in acute coronary syndrome: a word of caution

Abdul Hakeem*, MD; Aatish Garg, MD; Sabha Bhatti, MD; Zubair Ahmed, MD; Barry F. Uretsky, MD

A 42-year-old diabetic male presented with new onset typical cardiac chest pain. There were no ischaemic ECG changes and troponin was 0.13 ng/ml. Angiography showed a 60-70% lesion in the mid left anterior descending (LAD) artery without other lesions. Fractional flow reserve (FFR) evaluation was performed with a baseline pressure gradient of 0.94 (Figure 1) and FFR 0.89 despite increasing iv adenosine infusion from 140 to 180 mcg/kg/min and additional intracoronary adenosine (120, 240 and 360 mcg). Optical coherence tomography (OCT) showed a large thrombus burden in the mid LAD (MLD 1.27 mm, MLA 1.8 mm2) (Appendix Figure 1, Moving image 1). PCI with a drug-eluting stent was performed.

Figure 1. Baseline gradient (Pd/Pa) across mid LAD lesion.

A recent randomised trial suggested a role for FFR-guided management in acute coronary syndrome (ACS). In individual cases, hyperaemic flow may still be adequate to allow a “normal” FFR because other mechanisms have produced ischaemia, such as in the current case where the presence of fresh thrombus produced the ACS with an increased risk of adverse events. Given concerns about FFR measurement in ACS, probably secondary to an inability to achieve maximal hyperaemia, caution is warranted in interpreting FFR in such cases. Intracoronary imaging appears useful in such intermediate ACS cases.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Supplementary data

Moving image 1. OCT imaging run of distal to proximal LAD.

Appendix Figure 1. 70% stenosis in mid LAD on angiography. FFR of LAD 0.89. OCT imaging demonstrating normal-appearing vessel with large lumen (MLA 12.6 mm2, MLD 3.8 mm in the proximal LAD [A], and MLA 8.5 mm2, MLD 3.12 mm in the distal LAD [D]). Large red thrombus in the mid LAD (B & C) with significantly compromised lumen (MLA 1.8 mm2, MLD 1.2 mm).

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. OCT imaging run of distal to proximal LAD.

Volume 11 Number 8
Dec 20, 2015
Volume 11 Number 8
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV16I14A204 Feb 19, 2021
Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve
Echavarria-Pinto M and van de Hoef TP
free
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
35.3

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
26.25

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
26.25

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
19.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved